Catalio Capital Management, LP vs F-Prime Capital Partners
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Catalio Capital Management, LP | F-Prime Capital Partners | |
|---|---|---|
| Type | Crossover fund | Venture capital |
| HQ | New York | Cambridge |
| Founded | 2020 | 2002 |
| Check size | — | $3M – $10M |
| Stages | Seed, Series A, Series B, Series C, Growth, Late Stage | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Digital Health, Healthtech, Longevity, Medical Devices | Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, SaaS |
| AUM | $2.2B | $13B |
| Tracked investments | 106 | 378 |
| Exits (acquired/public) | 2 | 6 |
| Dated deals, last 24 mo | 3 | 5 |
Shared portfolio · 5
Avalyn Pharma IncEnsomaNeumora TherapeuticsOncusp TherapeuticsSingular Genomics Systems
Frequently asked questions
- Do Catalio Capital Management, LP and F-Prime Capital Partners invest together?
- Yes — Catalio Capital Management, LP and F-Prime Capital Partners appear together in 5 tracked portfolio companies, including Avalyn Pharma Inc, Ensoma, Neumora Therapeutics, Oncusp Therapeutics, Singular Genomics Systems.